ClinicalTrials.Veeva

Menu

Exploratory Study of Respiratory Bacterial Infections or Superinfections and Colonizations in Patients With Spinal Muscular Atrophy Under NIV (AVNIR)

C

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

Non Invasive Ventilation
Respiratory Bacterial Infection
Spinal Muscular Atrophy

Treatments

Other: non invasive ventilation samples
Other: patient samples
Other: parent questionnaire

Study type

Interventional

Funder types

Other

Identifiers

NCT05712330
PI2022_843_0095

Details and patient eligibility

About

SMA (Spinal Muscular Atrophy) is a rare neuromuscular disease characterized by motoneuron damage. Symptoms consist of respiratory involvement with numerous respiratory infections and eventually respiratory failure, for which NIV (Non Invasive Ventilation) is often used. Ventilation machines are in close contact with the respiratory tract of patients. They contain heated water to humidify the circuit. These humid and warm environments are conducive to the development of bacteria such as Pseudomonas aeruginosa. In this context, it is interesting to look for the presence or absence of bacteria, in comparison with the respiratory ecology of the patients. The aim is to highlight the microbiological role of NIV on the occurrence of respiratory bacterial infections or secondary infections in patients with SMA. To do this, samples are taken from the machines, and ECBCs are performed on patients during respiratory physiotherapy sessions.

Enrollment

8 patients

Sex

All

Ages

Under 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of AMS (previous diagnosis or new diagnosis during the inclusion period)
  • Age from 0 to 12 years old
  • Nusinersen treatment
  • Benefiting from a NIV
  • Current monitoring at the University Hospital of Amiens

Exclusion criteria

  • Invasive ventilation on tracheotomy
  • No ventilation
  • Other treatment than Nusinersen or no treatment
  • Parental refusal to participate in the study

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

non invasive ventilation
Experimental group
Description:
SMA patients with NIV
Treatment:
Other: parent questionnaire
Other: patient samples
Other: non invasive ventilation samples

Trial contacts and locations

1

Loading...

Central trial contact

Arnaud BECOURT, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems